COVID-19 Archives – Page 5 of 7 – Treatment Action Group

Investment in HIV Research Profoundly Benefits the COVID-19 Response

December 2, 2020
Dorrit Walsh

This policy brief discusses how investment in HIV research has profoundly benefitted the COVID-19 response, and advocates that continued financial support for HIV science can both ensure progress on COVID-19 and avoid losing ground—and lives—in the fight to end the HIV epidemic.

Efficacy News from Second COVID-19 Vaccine Trial Underscores Need for Transparency and Cooperation Between Outgoing and Incoming US Administrations

November 16, 2020
Dorrit Walsh

AVAC and Treatment Action Group (TAG) welcome today’s announcement that preliminary data from the efficacy trial of Moderna’s mRNA COVID-19 vaccine indicate high-level of protection against COVID-19.

COVID-19 and Impacted Communities: A Media Communications Guide

November 12, 2020
Dorrit Walsh

This easy-to-use guide is designed to provide journalists and communication professionals the tools needed to ensure accurate reporting and curb any related stigma associated with the novel coronavirus SARS-COV-2, also known and reported as COVID-19. We invite you to use this to inform your own writing and to share it with colleagues and cohorts that work in media and communications.

Treatment Action Group and AVAC Statement on Pfizer/BioNTech COVID-19 Vaccine Efficacy Announcement

November 9, 2020
Dorrit Walsh

Treatment Action Group (TAG) and AVAC welcome today’s announcement that preliminary data from the efficacy trial of Pfizer/BioNTech’s mRNA COVID-19 vaccine indicates a high level of protection against COVID-19. Our organizations urge caution, however, given the very limited information that is available only through a company press release.

TAG Welcomes the Election of Joseph R. Biden Jr. and Kamala D. Harris

November 9, 2020
Dorrit Walsh

Treatment Action Group (TAG) congratulates President-elect Joe Biden and Vice President-elect Kamala Harris on their ascension to the highest offices of the United States. Their victory in both the popular and electoral vote is historic.

Treatment Action Group Comments for the FDA Advisory Committee Meeting on COVID-19 Vaccines

October 20, 2020
Dorrit Walsh

TAG's comments and recommendations to the FDA Vaccines and Related Biological Products Advisory Committee, encompassing a broad range of community concerns regarding COVID-19 vaccine development and regulatory review.

TB Research Investments Provide Returns in Combating Both TB and COVID-19

September 4, 2020
Dorrit Walsh

As the COVID-19 pandemic continues to radically shift the global health landscape and alter government/donor commitments, TAG has released this timely brief to explore the impact of COVID-19 on TB research and development (R&D), and how tools, concepts, capacity, and…

Treatment Action Group Regrets NYC Health Commissioner Oxiris Barbot’s Resignation

August 6, 2020
Dorrit Walsh

Treatment Action Group, the New York City-based research, policy, and advocacy organization, deplores the August 4, 2020 departure of New York’s Department of Health Commissioner, Dr. Oxiris Barbot, MD.

Ensuring Universal Access to COVID-19 Diagnosis, Treatment and Prevention

July 27, 2020
Dorrit Walsh

TAG and the Center for Economic and Social Rights produced this joint publication, as part of CESR’s COVID-19 “Recovering Rights” series of briefs.

Civil Rights Groups, Health Advocates, and Public Defenders Celebrate Passage of Legislation to Protect Contact Tracing Data from Law Enforcement

July 23, 2020
Dorrit Walsh

TAG is one of the organizations who supports confidentiality in contact tracing and is applauding the passage of this legislation. As TAG's State and Local Policy Director Annette Gaudino says in this statement, “There can be no effective contact tracing without trust.”